Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Mayo Clinic
Bio-Path Holdings, Inc.
Stanford University
Stanford University
Karyopharm Therapeutics Inc
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Morphotek
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Indiana University
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Northwestern University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Roswell Park Cancer Institute
City of Hope Medical Center
Virginia Commonwealth University
Rutgers, The State University of New Jersey